Development of a New Class of Formyl Peptide Receptor 1 (FPR1) Biased Agonists for the Treatment of Myocardial Infarction

Project: Research

Project Details

Project Description

Cardiovascular disease is the leading cause of death, accounting for 30% of all global deaths. We have discovered a highly potent and novel compound that is unique in boosting a particular signalling pathway in heart tissue that can greatly improve recovery from heart attack, but this compound needs further optimization of properties that will enable it to be taken as a pill. This Development Grant will resource optimization of this novel drug candidate for the treatment of heart attack.
Effective start/end date1/01/2331/12/24